Literature DB >> 33966533

Non-Motor Symptoms of Parkinson's Disease: The Neurobiology of Early Psychiatric and Cognitive Dysfunction.

Ayan Hussein1,2, Christopher A Guevara1,2, Pamela Del Valle1,2, Swati Gupta1, Deanna L Benson1,2, George W Huntley1,2.   

Abstract

Parkinson's disease (PD) is a progressive neurodegenerative disorder that has been recognized for over 200 years by its clinically dominant motor system impairment. There are prominent non-motor symptoms as well, and among these, psychiatric symptoms of depression and anxiety and cognitive impairment are common and can appear earlier than motor symptoms. Although the neurobiology underlying these particular PD-associated non-motor symptoms is not completely understood, the identification of PARK genes that contribute to hereditary and sporadic PD has enabled genetic models in animals that, in turn, have fostered ever deepening analyses of cells, synapses, circuits, and behaviors relevant to non-motor psychiatric and cognitive symptoms of human PD. Moreover, while it has long been recognized that inflammation is a prominent component of PD, recent studies demonstrate that brain-immune signaling crosstalk has significant modulatory effects on brain cell and synaptic function in the context of psychiatric symptoms. This review provides a focused update on such progress in understanding the neurobiology of PD-related non-motor psychiatric and cognitive symptoms.

Entities:  

Keywords:  LRRK2; Parkinson’s disease; SNCA; Vps35; neurodegeneration; non-motor symptoms; social defeat stress; synaptic plasticity

Year:  2021        PMID: 33966533      PMCID: PMC9338765          DOI: 10.1177/10738584211011979

Source DB:  PubMed          Journal:  Neuroscientist        ISSN: 1073-8584            Impact factor:   7.235


  146 in total

Review 1.  Profile of cognitive impairment in Parkinson's disease.

Authors:  G Stennis Watson; James B Leverenz
Journal:  Brain Pathol       Date:  2010-05       Impact factor: 6.508

Review 2.  Inflammation is genetically implicated in Parkinson's disease.

Authors:  N Dzamko; C L Geczy; G M Halliday
Journal:  Neuroscience       Date:  2014-10-22       Impact factor: 3.590

3.  α-Syn suppression reverses synaptic and memory defects in a mouse model of dementia with Lewy bodies.

Authors:  Youngshin Lim; Victoria M Kehm; Edward B Lee; James H Soper; Chi Li; John Q Trojanowski; Virginia M-Y Lee
Journal:  J Neurosci       Date:  2011-07-06       Impact factor: 6.167

Review 4.  Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: From history to the interaction with the monoaminergic systems.

Authors:  E Faggiani; A Benazzouz
Journal:  Prog Neurobiol       Date:  2016-07-10       Impact factor: 11.685

Review 5.  Parkinson disease.

Authors:  Werner Poewe; Klaus Seppi; Caroline M Tanner; Glenda M Halliday; Patrik Brundin; Jens Volkmann; Anette-Eleonore Schrag; Anthony E Lang
Journal:  Nat Rev Dis Primers       Date:  2017-03-23       Impact factor: 52.329

Review 6.  Cognitive and psychiatric symptoms in genetically determined Parkinson's disease: a systematic review.

Authors:  R Piredda; P Desmarais; M Masellis; C Gasca-Salas
Journal:  Eur J Neurol       Date:  2019-11-28       Impact factor: 6.089

Review 7.  A progressive mouse model of Parkinson's disease: the Thy1-aSyn ("Line 61") mice.

Authors:  Marie-Francoise Chesselet; Franziska Richter; Chunni Zhu; Iddo Magen; Melanie B Watson; Sudhakar R Subramaniam
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

8.  Local control of AMPA receptor trafficking at the postsynaptic terminal by a small GTPase of the Rab family.

Authors:  Nashaat Z Gerges; Donald S Backos; José A Esteban
Journal:  J Biol Chem       Date:  2004-08-05       Impact factor: 5.157

9.  Anti-inflammatory effects of β-hydroxyisovalerylshikonin in BV2 microglia are mediated through suppression of the PI3K/Akt/NF-kB pathway and activation of the Nrf2/HO-1 pathway.

Authors:  Rajapaksha Gedara Prasad Tharanga Jayasooriya; Kyoung-Tae Lee; Hak-Ju Lee; Yung Hyun Choi; Jin-Woo Jeong; Gi-Young Kim
Journal:  Food Chem Toxicol       Date:  2013-12-21       Impact factor: 6.023

10.  Systematic proteomic analysis of LRRK2-mediated Rab GTPase phosphorylation establishes a connection to ciliogenesis.

Authors:  Martin Steger; Federico Diez; Herschel S Dhekne; Pawel Lis; Raja S Nirujogi; Ozge Karayel; Francesca Tonelli; Terina N Martinez; Esben Lorentzen; Suzanne R Pfeffer; Dario R Alessi; Matthias Mann
Journal:  Elife       Date:  2017-11-10       Impact factor: 8.140

View more
  4 in total

1.  Cognitive deficits and altered cholinergic innervation in young adult male mice carrying a Parkinson's disease Lrrk2G2019S knockin mutation.

Authors:  Ayan Hussein; Alexander Tielemans; Mark G Baxter; Deanna L Benson; George W Huntley
Journal:  Exp Neurol       Date:  2022-06-19       Impact factor: 5.620

Review 2.  The Pathological Mechanism Between the Intestine and Brain in the Early Stage of Parkinson's Disease.

Authors:  Runing Yang; Ge Gao; Hui Yang
Journal:  Front Aging Neurosci       Date:  2022-06-24       Impact factor: 5.702

Review 3.  The Double-Faceted Role of Leucine-Rich Repeat Kinase 2 in the Immunopathogenesis of Parkinson's Disease.

Authors:  Mengfei Zhang; Chaoyi Li; Jie Ren; Huakun Wang; Fang Yi; Junjiao Wu; Yu Tang
Journal:  Front Aging Neurosci       Date:  2022-05-11       Impact factor: 5.702

4.  Inflammatory gut as a pathologic and therapeutic target in Parkinson's disease.

Authors:  Jea-Young Lee; Zhen-Jie Wang; Alexa Moscatello; Chase Kingsbury; Blaise Cozene; Jeffrey Farooq; Madeline Saft; Nadia Sadanandan; Bella Gonzales-Portillo; Henry Zhang; Felipe Esparza Salazar; Alma Rosa Lezama Toledo; Germán Rivera Monroy; Reed Berlet; Cyndy D Sanberg; Paul R Sanberg; Cesario V Borlongan
Journal:  Cell Death Discov       Date:  2022-09-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.